NCT02960074View on ClinicalTrials.gov

Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

July 28, 2021

Study Completion Date

July 28, 2021

Conditions

Peanut Allergy

Interventions

BIOLOGICAL

Fecal Microbiota Capsule

We will treat patients with oral encapsulated frozen FMT over 2 days.

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors

lead

Rima Rachid

OTHER

NCT02960074 - Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients | Biotech Hunter | Biotech Hunter